Eiger BioPharmaceuticals, Inc. (EIGRQ) vs Purple Biotech Ltd. Sponsored ADR (PPBT)

Eiger BioPharmaceuticals, Inc. and Purple Biotech Ltd. Sponsored ADR are both Biotechnology companies. Eiger BioPharmaceuticals, Inc. and Purple Biotech Ltd. Sponsored ADR are of similar size ($2.6M and $2.4M). Purple Biotech Ltd. Sponsored ADR has the higher net margin (0.00% vs −475.3%) and the higher return on invested capital (−290.3% vs −3,674.6%). Across the 13 metrics below, Purple Biotech Ltd. Sponsored ADR leads on 7 and Eiger BioPharmaceuticals, Inc. on 6.

Valuation

Metric EIGRQ PPBT Biotechnology median
P/E n/m n/m 7.88
P/S 0.80 n/m 11.47
P/B n/m 0.13 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.14 0.74
EV/Sales 4.37 n/m 10.73
Earnings yield (601.00%) (3,301.47%) (28.84%)
Free cash flow yield (594.47%) (492.29%) (23.03%)

Profitability

Metric EIGRQ PPBT Biotechnology median
Gross margin 99.85% 0.00% 65.16%
Operating margin (455.12%) 0.00% 0.00%
Net margin (475.26%) 0.00% 0.00%
Free cash flow margin (474.11%) 0.00% 0.00%
Return on equity (367.00%) (110.67%) (57.72%)
Return on assets (94.31%) (100.91%) (49.22%)
Return on invested capital (3,674.55%) (290.25%) 0.00%

Growth

Metric EIGRQ PPBT Biotechnology median
Revenue growth (TTM) 16.98% — 5.64%
EPS growth (last fiscal year) 27.11% (10.14%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric EIGRQ PPBT Biotechnology median
Debt to equity (2.84) 0.00 0.00
Current ratio 0.71 3.70 4.73
Net debt to EBITDA (0.22) 0.35 0.96

Dividend

Metric EIGRQ PPBT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric EIGRQ PPBT Biotechnology median
Market cap 2.55m 2.40m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack